Generic Drug Approvals Account For Majority Of Formulary Changes, But CMS Says Requests Are Few
This article was originally published in The Pink Sheet Daily
CMS has received requests for changes for under 1% of the 450,000 formulary drugs in the Medicare program.
You may also be interested in...
Please take our brief reader survey to help us better understand your content and delivery needs.
A must-read selection of intriguing and popular articles posted in the Pink Sheet over the past three months.
Kite's CAR-T application seems to be sailing ahead without US FDA AdComm review; large employers in the US look into value-based contracting while European regulators band together on joint price negotiations; Teva is back at FDA with its EpiPen application. Policy Prescriptions rounds up recent regulatory news and trends reported by sister publication the Pink Sheet.